載入...
Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care
BACKGROUND: MP-AzeFlu (Dymista®; spray of azelastine/fluticasone propionate) is the most effective allergic rhinitis (AR) treatment available. Its effect on asthma outcomes in patients with AR and asthma is unknown. METHODS: This pre-post historical cohort study, using the Optimum Patient Care Resea...
Na minha lista:
| 發表在: | World Allergy Organ J |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
World Allergy Organization
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753940/ https://ncbi.nlm.nih.gov/pubmed/33376573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2020.100490 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|